Results
9
Companies which are more than 50% undervalued based on analyst price target.
9 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VWS | DKK 103.50 | 6.2% | -46.6% | DKK 104.1b | DKK 156.08 | PE28x | E23.7% | 0.5% | Capital Goods | ||
GMAB | DKK 1,367.50 | -1.9% | -28.3% | DKK 86.9b | DKK 2,292.13 | PE18.5x | E21.4% | n/a | Pharmaceuticals & Biotech | ||
BAVA | DKK 173.55 | -7.2% | 7.8% | DKK 13.5b | DKK 305.00 | PE12.1x | E-0.2% | n/a | Pharmaceuticals & Biotech | ||
DNORD | DKK 190.70 | -3.7% | -42.5% | DKK 5.7b | DKK 307.64 | PE4.8x | E24.3% | 4.2% | Transportation | ||
DFDS New | DKK 105.20 | 3.1% | -49.9% | DKK 5.7b | DKK 160.33 | PE5.8x | E24.5% | 2.9% | Transportation | ||
NTG | DKK 234.50 | 0.9% | -23.4% | DKK 5.0b | DKK 385.24 | PE15.9x | E16.6% | n/a | Transportation | ||
NLFSK New | DKK 109.60 | -0.4% | -14.6% | DKK 3.0b | DKK 166.67 | PE10.9x | E23.0% | n/a | Capital Goods | ||
BIOPOR | DKK 1.51 | 3.0% | -29.3% | DKK 647.1m | DKK 3.00 | PS18.5x | E-27.8% | n/a | Pharmaceuticals & Biotech | ||
GREENH | DKK 3.05 | 4.7% | -48.9% | DKK 572.6m | DKK 4.90 | PS9.6x | E23.4% | n/a | Capital Goods |